Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
about
Augmentation with antidepressants in schizophrenia treatment: benefit or riskQuetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.Glutamatergic model psychoses: prediction error, learning, and inferenceBeing in a process of transition to psychosis, as narrated by adults with psychotic illnesses acutely admitted to hospital.Prevalence of comorbid anxiety disorders in schizophrenia.Increased use of primary care during 6 years of prodromal schizophrenia.Sleep in Schizophrenia: Exploring Subjective Experiences of Sleep Problems, and Implications for Treatment.Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.First self-perceived signs and symptoms in emerging psychosis compared with depression.Mapping the evidence on pharmacological interventions for non-affective psychosis in humanitarian non-specialised settings: a UNHCR clinical guidance.Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis.Negative symptoms of psychosis: A life course approach and implications for prevention and treatment.The impact of caregiver familiarity with mental disorders on timing of intervention in first-episode psychosis.
P2860
Q26851841-CDB67059-71C9-49D0-8728-8D1575667E18Q30389701-A62CC4E5-D22A-4488-A81A-7AEE1CD604FEQ30467190-9D729586-B832-43C7-8D2F-FA501BBDF653Q30473707-583B59A6-70FF-4E02-A8CD-E9857366A655Q30485438-5FA2354D-DE97-4485-A276-13295D13ECDAQ34626655-AAF874EB-C672-4D4F-A30F-561066D51099Q34661231-B441A222-27E5-489E-A45F-4328C54301C8Q34679078-10FADCD3-B457-40D1-857C-D8D3652D972BQ37595603-97A81164-B53C-4A8B-A91C-5C8097D062DAQ39687694-61024A7F-E671-4AA5-AD64-C4E5A34EFAECQ40188895-01A40CAF-B84C-467E-8982-D95B00E2B03FQ41651638-82D2C4E7-6CC0-4135-8003-1698EE53B541Q45713567-7DE2437D-76B4-4BAB-A96F-312B5F0ADDDAQ47100336-5C79D33A-F783-4A60-A9CE-517202D4B5E2Q47564936-9AF4812F-5415-4F06-99C7-B8C08C498ED8Q47587674-8FF0E7DE-59AC-4DA3-926C-DC8821382828Q50663026-46A8F088-512F-4175-8C8E-0B76AA9FD635
P2860
Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Signs and symptoms in the pre- ...... s for diagnostic trajectories.
@en
type
label
Signs and symptoms in the pre- ...... s for diagnostic trajectories.
@en
prefLabel
Signs and symptoms in the pre- ...... s for diagnostic trajectories.
@en
P2093
P2860
P1476
Signs and symptoms in the pre- ...... ns for diagnostic trajectories
@en
P2093
P2860
P304
P356
10.1017/S0033291708003152
P407
P50
P577
2008-03-26T00:00:00Z